|
KOREA LAB Autumn
|
CBIS
|
Q-omics - A Bio-LDM?powered Bio-AI platform that discovers drug targets, biomarkers, and response/resistance mechanisms from proprietary omics data, then validates them with large-scale patient and cell-line evidence.
|
F16/F60
|
|
NextRegenX
|
CEFO Co., Ltd.
|
Stem Cell-based Bone Regeneration Therapy and NK Cell Immunotherapy
|
B61
|
|
KOREA LIFE SCIENCE
|
CELLCURATIO Co., Ltd.
|
① Plant-Derived Extracellular Vesicles ② Keratinocyte Growth Factor[KGF-1(FGF7), KGF-2 (FGF10)]
|
E61
|
|
KOREA LIFE SCIENCE
|
CellNBetter
|
LOCAT
|
D61
|
|
NextRegenX
|
Celloid Co., Ltd.
|
Automated production system for highly uniform and mature organoids based on nanofibrous microwell
|
B36
|
|
NextRegenX
|
CellSafe Co., Ltd.
|
NAT based Kits for bio-safety: Mycoplasma Testing, Replication-Competent Virus, Residual Host Cell DNA, etc.
|
A16
|
|
KOREA LAB Autumn
|
CEM
|
Microwave Organic/Inorganic & Peptide Synthesis System, Flow Imaging Microscope, Bench-top NMR, FT-IR
|
G31
|
|
NextRegenX
|
Central Link Co
|
Serum-Free Chemically Defined Cell Culture Media for Cell & Gene Therapy
|
B24
|
|
KOREA LAB Autumn
|
Charles River Laboratories Korea
|
Microbial Quality Control Solutions, Preclinical CRO & Bioanalytical Services for Drug Development
|
E12
|
|
KOREA LIFE SCIENCE
|
Checkmate Therapeutics Co., Ltd.
|
Discovery and Development of First-in-Class Small-Molecule Oncology Therapeutics based on Functional and Chemical Genomics
|
H50
|
KYUNGYON EXHIBITION CORP.
